| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non–Small-cell Lung Cancer
|
Li, Kun-lin
|
|
2017
|
18 |
3 |
p. 340-343
|
artikel
|
| 2 |
A Multimedia Self-management Intervention to Prepare Cancer Patients and Family Caregivers for Lung Surgery and Postoperative Recovery
|
Sun, Virginia
|
|
2017
|
18 |
3 |
p. e151-e159
|
artikel
|
| 3 |
Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non–Small-Cell Lung Cancer
|
Saba, Nabil F.
|
|
2017
|
18 |
3 |
p. e203-e210
|
artikel
|
| 4 |
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non–Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial
|
Gautschi, Oliver
|
|
2017
|
18 |
3 |
p. 303-309
|
artikel
|
| 5 |
Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non–Small-cell Lung Cancer
|
Tembhekar, Amode R.
|
|
2017
|
18 |
3 |
p. 293-298
|
artikel
|
| 6 |
Definitive Radiotherapy for Local Recurrence of NSCLC After Surgery
|
Wu, Abraham J.
|
|
2017
|
18 |
3 |
p. e161-e168
|
artikel
|
| 7 |
Durable Response to Combination of Dabrafenib and Trametinib in BRAF V600E-Mutated Non–small-cell Lung Cancer
|
Pervere, Leah M.
|
|
2017
|
18 |
3 |
p. e211-e213
|
artikel
|
| 8 |
Editorial Board
|
|
|
2017
|
18 |
3 |
p. A2
|
artikel
|
| 9 |
Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma
|
Genestreti, Giovenzio
|
|
2017
|
18 |
3 |
p. e215-e217
|
artikel
|
| 10 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer
|
Lin, Yen-Ting
|
|
2017
|
18 |
3 |
p. 324-332.e1
|
artikel
|
| 11 |
Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non–Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center
|
Dinglin, Xiao-xiao
|
|
2017
|
18 |
3 |
p. e179-e186
|
artikel
|
| 12 |
Evolution of Symptom Burden of Advanced Lung Cancer Over a Decade
|
Sung, Mike R.
|
|
2017
|
18 |
3 |
p. 274-280.e6
|
artikel
|
| 13 |
Genomic Profiling of Circulating Tumor DNA in Relapsed EGFR-mutated Lung Adenocarcinoma Reveals an Acquired FGFR3-TACC3 Fusion
|
Allen, Justin M.
|
|
2017
|
18 |
3 |
p. e219-e222
|
artikel
|
| 14 |
Immunohistochemistry for EGFR Mutation Detection in Non–Small-Cell Lung Cancer
|
Hitij, Nina Turnšek
|
|
2017
|
18 |
3 |
p. e187-e196
|
artikel
|
| 15 |
Molecular Profiling and Survival of Completely Resected Primary Pulmonary Neuroendocrine Carcinoma
|
Lou, Guangyuan
|
|
2017
|
18 |
3 |
p. e197-e201
|
artikel
|
| 16 |
Non–Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non–Small-cell Lung Cancer Favor Adenocarcinoma
|
Shiran, Iris
|
|
2017
|
18 |
3 |
p. 316-323.e1
|
artikel
|
| 17 |
Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non–Small-cell Lung Cancer
|
Schneider, Bryan J.
|
|
2017
|
18 |
3 |
p. 299-302
|
artikel
|
| 18 |
Postoperative Adjuvant Systemic Therapy in Completely Resected Non–Small-Cell Lung Cancer: A Systematic Review
|
Bradbury, Penelope
|
|
2017
|
18 |
3 |
p. 259-273.e8
|
artikel
|
| 19 |
Practice Patterns of Thoracic Radiotherapy for Extensive-Stage Small-Cell Lung Cancer: Survey of US Academic Thoracic Radiation Oncologists
|
Post, Carl M.
|
|
2017
|
18 |
3 |
p. 310-315.e1
|
artikel
|
| 20 |
Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non–Small-Cell Lung Cancer
|
Lara, Matthew S.
|
|
2017
|
18 |
3 |
p. 281-285
|
artikel
|
| 21 |
Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base
|
Steuer, Conor E.
|
|
2017
|
18 |
3 |
p. 286-292
|
artikel
|
| 22 |
Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non–Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy
|
Lim, Yu Jin
|
|
2017
|
18 |
3 |
p. e169-e178
|
artikel
|
| 23 |
Table of Contents
|
|
|
2017
|
18 |
3 |
p. A4-A8
|
artikel
|
| 24 |
The Use of Antiangiogenic Agents for Lung Cancer in Elderly Patients: An Expert Panel Discussion Synopsis
|
Socinski, Mark A.
|
|
2017
|
18 |
3 |
p. 255-258
|
artikel
|
| 25 |
Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non–Small-Cell Lung Cancer (RTOG 3505)
|
Gerber, David E.
|
|
2017
|
18 |
3 |
p. 333-339
|
artikel
|
Tijdschrift beschrijving